rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1999-4-16
|
pubmed:abstractText |
After 2 weeks of nicorandil therapy, time to ischemia on stress testing was significantly less than on day 1 and not different from placebo. These data are consistent with attenuation of the anti-ischemic effects of this drug and suggest that the potassium channel-opening properties do not compensate for development of attenuation to the nitrate component of nicorandil.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0002-9149
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1120-4, A9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10190531-Adrenergic beta-Antagonists,
pubmed-meshheading:10190531-Adult,
pubmed-meshheading:10190531-Aged,
pubmed-meshheading:10190531-Angina Pectoris,
pubmed-meshheading:10190531-Blood Pressure,
pubmed-meshheading:10190531-Calcium Channel Blockers,
pubmed-meshheading:10190531-Cross-Over Studies,
pubmed-meshheading:10190531-Diltiazem,
pubmed-meshheading:10190531-Double-Blind Method,
pubmed-meshheading:10190531-Electrocardiography,
pubmed-meshheading:10190531-Exercise Test,
pubmed-meshheading:10190531-Female,
pubmed-meshheading:10190531-Heart Rate,
pubmed-meshheading:10190531-Humans,
pubmed-meshheading:10190531-Male,
pubmed-meshheading:10190531-Middle Aged,
pubmed-meshheading:10190531-Myocardial Ischemia,
pubmed-meshheading:10190531-Nicorandil,
pubmed-meshheading:10190531-Time Factors,
pubmed-meshheading:10190531-Verapamil
|
pubmed:year |
1999
|
pubmed:articleTitle |
Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.
|
pubmed:affiliation |
Department of Cardiology, Concord Repatriation General Hospital, University of Sydney, Australia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|